Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.32 USD | +0.72% | +0.64% | +25.55% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.55% | 10.12B | |
+26.78% | 661B | |
+27.43% | 566B | |
-6.41% | 352B | |
+20.60% | 332B | |
+2.46% | 283B | |
+13.76% | 231B | |
+5.16% | 200B | |
-9.12% | 195B | |
-5.00% | 145B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Baird Upgrades Catalent to Outperform From Neutral, Raises Price Target to $53 From $45